A detailed history of Jacobs Levy Equity Management, Inc transactions in Inogen Inc stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 290,868 shares of INGN stock, worth $2.45 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
290,868
Previous 310,356 6.28%
Holding current value
$2.45 Million
Previous $2.52 Million 11.81%
% of portfolio
0.01%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$7.67 - $12.98 $149,472 - $252,954
-19,488 Reduced 6.28%
290,868 $2.82 Million
Q2 2024

Aug 14, 2024

SELL
$6.3 - $8.95 $390,486 - $554,738
-61,982 Reduced 16.65%
310,356 $2.52 Million
Q1 2024

May 15, 2024

SELL
$5.26 - $10.15 $480,169 - $926,563
-91,287 Reduced 19.69%
372,338 $3 Million
Q4 2023

Feb 14, 2024

BUY
$4.21 - $6.32 $270,711 - $406,388
64,302 Added 16.1%
463,625 $2.55 Million
Q3 2023

Nov 16, 2023

BUY
$5.14 - $11.28 $79,520 - $174,512
15,471 Added 4.03%
399,323 $2.08 Million
Q2 2023

Aug 14, 2023

BUY
$10.01 - $13.86 $256,806 - $355,578
25,655 Added 7.16%
383,852 $4.43 Million
Q1 2023

May 15, 2023

BUY
$11.88 - $26.0 $1.25 Million - $2.73 Million
105,017 Added 41.48%
358,197 $4.47 Million
Q4 2022

Feb 14, 2023

SELL
$19.14 - $24.55 $28,805 - $36,947
-1,505 Reduced 0.59%
253,180 $4.99 Million
Q3 2022

Nov 15, 2022

SELL
$22.74 - $31.8 $876,172 - $1.23 Million
-38,530 Reduced 13.14%
254,685 $6.18 Million
Q2 2022

Aug 15, 2022

BUY
$22.88 - $35.28 $297,828 - $459,239
13,017 Added 4.65%
293,215 $7.09 Million
Q1 2022

May 16, 2022

BUY
$28.1 - $35.25 $473,119 - $593,504
16,837 Added 6.39%
280,198 $9.08 Million
Q4 2021

Feb 14, 2022

BUY
$29.66 - $44.0 $2.65 Million - $3.93 Million
89,326 Added 51.33%
263,361 $8.95 Million
Q3 2021

Nov 15, 2021

BUY
$43.09 - $82.26 $6.8 Million - $13 Million
157,785 Added 970.98%
174,035 $7.5 Million
Q2 2021

Aug 16, 2021

BUY
$52.03 - $68.77 $845,487 - $1.12 Million
16,250 New
16,250 $1.06 Million
Q1 2019

May 14, 2019

SELL
$90.12 - $152.23 $700,142 - $1.18 Million
-7,769 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$112.83 - $239.74 $766,341 - $1.63 Million
-6,792 Reduced 46.65%
7,769 $965,000
Q3 2018

Nov 14, 2018

SELL
$189.1 - $282.92 $1.62 Million - $2.43 Million
-8,579 Reduced 37.07%
14,561 $3.56 Million
Q2 2018

Aug 14, 2018

SELL
$123.8 - $192.48 $70,566 - $109,713
-570 Reduced 2.4%
23,140 $4.31 Million
Q1 2018

May 15, 2018

BUY
$114.22 - $133.22 $1.31 Million - $1.53 Million
11,470 Added 93.71%
23,710 $2.91 Million
Q4 2017

Feb 13, 2018

BUY
$93.4 - $128.74 $205,480 - $283,228
2,200 Added 21.91%
12,240 $1.46 Million
Q3 2017

Nov 14, 2017

BUY
$91.08 - $104.49 $292,366 - $335,412
3,210 Added 47.0%
10,040 $955,000
Q2 2017

Nov 09, 2017

BUY
N/A
6,830
6,830 $652,000

Others Institutions Holding INGN

About Inogen Inc


  • Ticker INGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 22,866,500
  • Market Cap $193M
  • Description
  • Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...
More about INGN
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.